News

March 08, 2023

BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome

Article

February 03, 2023

BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
 
Article

January 25, 2023

2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies

Article

October 13, 2022

A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field

Article

August 31, 2022

Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst

Article

August 23, 2022

Giving Metabolism A Boost? BioRestorative Uses Science Surrounding Brown Fat Cells To Provide A Possible Breakthrough In Metabolic Disorders

Article

July 27, 2022

This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence

Article
Videos

March 21, 2023

BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome

March 17, 2023

BioRestorative Therapies Inc. on Stem Cell Therapies to Help Patients with Prevalent Conditions

October 06, 2022

Molecular Biosciences Professor Dr. Tore Bengtsson Weighs in on $BRTX’s Metabolic Health Pursuits

October 04, 2022

BioRestorative Therapies underway with Phase 2 clinical trial on stem cell-based BRTX-100

August 17, 2022

Lance Alstodt and Francisco Silva
© 2025. BioRestorative Therapies, Inc. All rights reserved.